health
Plasma Neoepitope Search Hit Limits in a Four-Patient Study
A bioRxiv preprint reports that plasma mass spectrometry could detect some tumor-associated peptides, but neoepitope searches were constrained by limited overlap between cfDNA and tumor mutations and by MS sensitivity. Tissue remained the stronger reference for identifying tumor mutations and neoepitopes.